Clinical trial
Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu
NCT00347529 · PowderMed, Industry · Completed
Key facts
| NCT number | NCT00347529 |
|---|---|
| Title | Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu |
| Official title | A Randomised Double Blind Dose-Ranging Study to Assess the Safety, Tolerability and Immunogenicity of a Monovalent H5 DNA Influenza Vaccine (A Vietnam/1194/2004) Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Adults |
| Lead sponsor | PowderMed, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza (Pandemic) |
| Intervention type | Biological |
| Interventions | pPML7789 with and without pPJV2012 administered by PMED |
| Enrollment | 75 |
| Start date | Aug 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Jan 29, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: